10/26/2018
`
`Spain's Almirall bets on dermatology with $650 million U.S. deal | Reuters
`
`DEALS
`AUGUST 3, 2018 / 4:30 AM / 3 MONTHS AGO
`
`Spain's Almirall bets on dermatology with $650 million U.S.
`deal
`
`(Reuters) - Spanish pharmaceutical company Almirall (ALM.MC) said on Friday it had agreed
`to buy five dermatology brands from U.S. company Allergan (AGN.N) for up to $650 million
`in cash.
`
`The deal will make dermatology into Almirall’s main growth driver, increasing the business’s
`net sales to nearly 45 percent of the group total from 34 percent, Almirall said.
`
`“This is a transformational deal for Almirall. It will reinforce and consolidate our position in
`the world’s largest dermatology market.”, Almirall chief executive Peter Guenter said.
`
`The portfolio includes four already marketed acne products and a new brand Seysara which is
`pending an FDA approval.
`
`S P O N S O R E D
`
`https://www.reuters.com/article/us-allergan-m-a-almirall/spains-almirall-bets-on-dermatology-with-650-million-us-deal-idUSKBN1KO10N
`
`1/8
`
`Imprisoned In Myanmar
`
`Energy & Environment
`
`Brexit
`
`North Korea
`
`Charged: The Future of Autos
`
`Fut
`
`Mylan (IPR2019-01095) MYLAN1031, p. 001
`
`
`
`Spain's Almirall bets on dermatology with $650 million U.S. deal | Reuters
`
`DEALS
`AUGUST 3, 2018 / 4:30 AM / 3 MONTHS AGO
`
`Spain's Almirall bets on dermatology with $650 million U.S.
`deal
`
`(Reuters) - Spanish pharmaceutical company Almirall (ALM.MC) said on Friday it had agreed
`to buy five dermatology brands from U.S. company Allergan (AGN.N) for up to $650 million
`in cash.
`
`The deal will make dermatology into Almirall’s main growth driver, increasing the business’s
`net sales to nearly 45 percent of the group total from 34 percent, Almirall said.
`
`“This is a transformational deal for Almirall. It will reinforce and consolidate our position in
`the world’s largest dermatology market.”, Almirall chief executive Peter Guenter said.
`
`The portfolio includes four already marketed acne products and a new brand Seysara which is
`pending an FDA approval.
`
`S P O N S O R E D
`
`https://www.reuters.com/article/us-allergan-m-a-almirall/spains-almirall-bets-on-dermatology-with-650-million-us-deal-idUSKBN1KO10N
`
`1/8
`
`Imprisoned In Myanmar
`
`Energy & Environment
`
`Brexit
`
`North Korea
`
`Charged: The Future of Autos
`
`Fut
`
`Mylan (IPR2019-01095) MYLAN1031, p. 001
`
`
`
`10/26/2018
`
`Spain's Almirall bets on dermatology with $650 million U.S. deal | Reuters
`
`There’s a new name
`in the energy game.
`
`Statoil has changed its name to Equinor.
`
`Almirall expects Seysara to generate sales up to $200 million at its peak.
`
`Ad
`
`Magic: The Gathering Arena
`Play the deepest strategy card game today. Download Now for Free on PC.
`WIZARDS OF THE COAST
`
`Download
`
`Almirall said it would pay $550 million in cash upfront and up to $100 million in an “earn-out”
`based on the brands’ performance.
`
`The skin-health focused company said the purchase would
`
`add to its earnings from 2019 onwards as it expects to close the deal by the fourth quarter of
`2018.
`
`Reporting by Katarzyna Zajaczkowska in Gdynia; editing by Jason Neely and Jane Merriman
`
`Our Standards: The Thomson Reuters Trust Principles.
`
`https://www.reuters.com/article/us-allergan-m-a-almirall/spains-almirall-bets-on-dermatology-with-650-million-us-deal-idUSKBN1KO10N
`
`2/8
`
`Mylan (IPR2019-01095) MYLAN1031, p. 002
`
`
`
`10/26/2018
`M O R E F R O M R E U T E R S
`
`TOP ARTICLES
`
`1/5
`
`Spain's Almirall bets on dermatology with $650 million U.S. deal | Reuters
`
` 00:14 / 00:15
`Exclusive: Airbus to name outsider after board hastened CFO's exit
`- sources
`
`READ MORE
`
`S P O N S O R E D
`
`This Amazon Upgrade is Even Better
`Than Prime
`Honey
`
`Don’t Keep Using The Same Credit
`Card (Do This Instead)
`CompareCards.com
`
`Credit Cards with Massive Rewards for
`World Travellers
`NerdWallet
`
`Evaluate your trades: it's time to focus
`on pre-trade planning.
`From BofAML
`
`Learn how Trusts can reduce your
`financial risk & protect your family
`Hawthorn PNCFamilyWealth®
`
`The bond market is changing. What
`should you watch out for?
`Morgan Stanley Investment Mgmt
`
`Promoted by Dianomi
`
`https://www.reuters.com/article/us-allergan-m-a-almirall/spains-almirall-bets-on-dermatology-with-650-million-us-deal-idUSKBN1KO10N
`
`3/8
`
`Mylan (IPR2019-01095) MYLAN1031, p. 003
`
`
`
`10/26/2018
`
`Spain's Almirall bets on dermatology with $650 million U.S. deal | Reuters
`
`BUSINESS NEWS
`OCTOBER 26, 2018 / 2:39 PM / UPDATED 4 MINUTES AGO
`
`Tesla says has not received subpoena on Model 3 production
`
`Alexandria Sage, Arjun Panchadar
`
`SAN FRANCISCO (Reuters) - Tesla Inc (TSLA.O) has not received a U.S. subpoena related to
`its Model 3 production forecasts, the electric carmaker said on Friday, following a report that
`it faced a deepening criminal probe about the projections.
`
`https://www.reuters.com/article/us-allergan-m-a-almirall/spains-almirall-bets-on-dermatology-with-650-million-us-deal-idUSKBN1KO10N
`
`4/8
`
`Mylan (IPR2019-01095) MYLAN1031, p. 004
`
`
`
`10/26/2018
`
`Spain's Almirall bets on dermatology with $650 million U.S. deal | Reuters
`
`FILE PHOTO: A Tesla charging station is seen in Salt Lake City, Utah, U.S., September 28, 2017. REUTERS/Lucy
`Nicholson/File Photo
`
`The company has cooperated in responding to what it called a “voluntary request” for
`documents from the Department of Justice in September, a Tesla spokesperson said. The
`agency has the ability to press criminal charges.
`
`“We have not received a subpoena, a request for testimony, or any other formal process, and
`there have been no additional document requests about this from the Department of Justice
`for months,” the spokesperson said in an email.
`
`The Federal Bureau of Investigation is examining whether Tesla misstated information about
`the production of its Model 3 sedans and misled investors about its business going back to
`early 2017, the Wall Street Journal reported, citing sources.
`
`In recent weeks, FBI agents have contacted former Tesla employees to seek testimony in the
`criminal case, according to the report. The ex-employees received subpoenas earlier in the
`probe, and FBI agents recently have sought to interview a number of them, the sources said.
`
`Any focus on Tesla’s past statements about Model 3 production targets would broaden the
`probe by the agency, which Tesla said last month was looking at statements made by Chief
`Executive Elon Musk about a go-private deal that was later called off.
`
`https://www.reuters.com/article/us-allergan-m-a-almirall/spains-almirall-bets-on-dermatology-with-650-million-us-deal-idUSKBN1KO10N
`
`5/8
`
`Mylan (IPR2019-01095) MYLAN1031, p. 005
`
`
`
`Spain's Almirall bets on dermatology with $650 million U.S. deal | Reuters
`10/26/2018
`Tesla first disclosed in September that the DoJ was investigating Musk’s tweets about having
`“funding secured” for a deal to take Tesla private, saying the agency had asked for documents
`about such statements.
`
`Any expansion of the FBI’s probe comes as Musk faces pressure to deliver consistent
`production of the Model 3 at a profit. The company on Wednesday posted a profit and positive
`cash flow, making good on pledges made by Musk earlier this year, as the company ramps up
`volume of its new sedan.
`
`MODEL 3 CHALLENGES
`
`Tesla and Musk already face a proposed class action shareholder lawsuit claiming that the
`company and its top executives made false statements about the readiness of the Model 3 for
`volume production.
`
`The car, which the money-losing company is banking on to turn a profit, was introduced to the
`public in early 2016 to great fanfare, with repeated promises throughout 2017 that Tesla was
`“on track” to build 5,000 Model 3s per week by the end of that year at its factory in Fremont,
`California.
`
`Such statements were fraudulent, according to the lawsuit, given that the automated assembly
`lines to build the car in such volume were behind schedule.
`
`Tesla has denied the claims in the lawsuit, saying it disclosed production bottlenecks once they
`were identified, and citing Musk’s public statements that the company was undergoing a
`period of “production hell” in 2017.
`
`https://www.reuters.com/article/us-allergan-m-a-almirall/spains-almirall-bets-on-dermatology-with-650-million-us-deal-idUSKBN1KO10N
`
`6/8
`
`Mylan (IPR2019-01095) MYLAN1031, p. 006
`
`
`
`10/26/2018
`
`Spain's Almirall bets on dermatology with $650 million U.S. deal | Reuters
`
`Tesla posts profit; shares soar
`
`Tesla only reached a goal to build 5,000 Model 3s per week in June, although current
`production has fallen short of that.
`
`Musk and Tesla only recently settled with the U.S. Securities and Exchange Commission over
`Musk’s Aug. 7 tweets. The SEC sued him for fraud, calling his claims “false and misleading,”
`before reaching a settlement.
`
`Both Tesla and Musk must pay a $20 million fine, and Musk must give up his chairman role for
`three years as the company appoints an independent chair.
`
`Shares of Tesla rose 4.5 to $329, extending their rally following bullish results on Wednesday.
`
`Reporting by Arjun Panchadar in Bengaluru; Editing by Shounak Dasgupta, Sai Sachin Ravikumar and
`Richard Chang
`
`Our Standards: The Thomson Reuters Trust Principles.
`
`Apps Newsletters Advertise with Us Advertising Guidelines Cookies
`
`Terms of Use Privacy
`
`https://www.reuters.com/article/us-allergan-m-a-almirall/spains-almirall-bets-on-dermatology-with-650-million-us-deal-idUSKBN1KO10N
`
`7/8
`
`Mylan (IPR2019-01095) MYLAN1031, p. 007
`
`
`
`10/26/2018
`
`Spain's Almirall bets on dermatology with $650 million U.S. deal | Reuters
`
`All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
`
`© 2018 Reuters. All Rights Reserved.
`
`https://www.reuters.com/article/us-allergan-m-a-almirall/spains-almirall-bets-on-dermatology-with-650-million-us-deal-idUSKBN1KO10N
`
`8/8
`
`Mylan (IPR2019-01095) MYLAN1031, p. 008
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
